Articles From: OFG Bancorp Reports 3Q13 Results to Ducommun Reports Results for the Third Quarter Ended September 28, 2013


OFG Bancorp (NYSE:OFG) reported today results for the third quarter ended September 30, 2013.
Sign-up for OFG Bancorp Reports 3Q13 Results investment picks
2013/10/28
Amkor Technology, Inc. (NASDAQ: AMKR), a leading provider of semiconductor packaging and test services, today announced financial results for the third quarter ended September 30, 2013, with net sales of $768 million, net income of $25 million, and earnings per diluted share of $0.11. “Third quarter sales were up 10% year-over-year and 3% sequentially,” said Steve Kelley, Amkor's president and chief executive officer.
Sign-up for Amkor Technology Reports Financial Results for the Third Quarter 2013 investment picks
ChannelAdvisor Corporation (NYSE: ECOM), a leading provider of cloud-based e-commerce solutions that enable retailers and manufacturers to increase global sales, today announced its financial results for the quarter ended September 30, 2013.
Sign-up for ChannelAdvisor Announces Third Quarter 2013 Financial Results investment picks
Cognex Corporation (NASDAQ: CGNX) today announced its financial results for the third quarter of 2013.
Sign-up for Cognex Reports Record Quarterly Revenue and Record Quarterly Net Income investment picks
2013/10/28
EPS - Diluted of $0.35 FFO Per Share - Diluted, as Adjusted, of $1.06 AFFO Per Share - Diluted of $0.99 Total Revenues of $158.6 Million NOI of $110.9 Million Significant Delivery of Value-Creation Projects PASADENA, Calif.
Sign-up for Alexandria Real Estate Equities, Inc. Reports Third Quarter Ended September 30, 2013 Financial and Operating Results investment picks
2013/10/28
Net loss of $8.7 million or $(0.06) per common share Core earnings of $67.5 million or $0.50 per common share * Book Value of $17.64 per common share ATLANTA , Oct.
Sign-up for Invesco Mortgage Capital Inc. Reports Third Quarter 2013 Financial Results investment picks
2013/10/28
Sophiris Announces First Patients Dosed in the "PLUS-1" Phase 3 Trial of PRX302 for Benign Prostatic Hyperplasia Canada NewsWire PRX302 is highly targeted to prostate tissue and is delivered directly to the prostate via a localized injection.
Sign-up for Sophiris Announces First Patients Dosed in the "PLUS-1" Phase 3 Trial of PRX302 for Benign Prostatic Hyperplasia investment picks
Sophiris Bio Inc. (NASDAQ: SPHS) (TSX: SHS) today announced that enrollment has begun and the first patients have been dosed in a Phase 3 trial of PRX302 (topsalysin) as a treatment for lower urinary tract symptoms of benign prostatic hyperplasia (BPH or enlarged prostate). The Phase 3 international, multi-center study, called the PLUS-1 study, will enroll approximately 440 patients.
Sign-up for Sophiris Announces First Patients Dosed in the “PLUS-1” Phase 3 Trial of PRX302 for Benign Prostatic Hyperplasia investment picks
2013/10/28
The Corporate Executive Board Company (“CEB” or the “Company”) (NYSE: CEB) today announces financial results for the third quarter and nine months ended September 30, 2013.
Sign-up for CEB Reports Third Quarter Results and Updates 2013 Guidance investment picks
2013/10/28
HomeStreet, Inc. (NASDAQ:HMST) (the “Company” or “HomeStreet”), the parent company of HomeStreet Bank (the “Bank”), today announced net income of $1.7 million, or $0.11 per diluted share, for the third quarter of 2013, compared to net income of $12.1 million, or $0.82 per share, for the second quarter of 2013 and $22.0 million, or $1.50 per share, for the third quarter of 2012.
Sign-up for HomeStreet, Inc. Reports Third Quarter 2013 Results investment picks
Vishay Intertechnology, Inc. (NYSE: VSH), one of the world’s largest manufacturers of discrete semiconductors and passive components, today announced various cost reduction programs as part of its continuous efforts to improve efficiency and operating performance.
Sign-up for Vishay Intertechnology Announces Cost Reduction Programs investment picks
2013/10/28
http://media.marketwire.com/attachments/201210/52482_theravance_logo.jpg http://at.marketwire.com/accesstracking/AccessTrackingLogServlet?PrId=1062995&ProfileId=051205&sourceType=1 SOUTH SAN FRANCISCO, CA --
Sign-up for Theravance Appoints Jeff Jonker Senior Vice President, Corporate and Business Development investment picks
Kaman Corp.
Sign-up for Kaman Reports 2013 Third Quarter Results investment picks
2013/10/28
Revenue In Line with Guidance PLAINSBORO, N.J., Oct.
Sign-up for Integra LifeSciences Reports Third Quarter 2013 Financial Results investment picks
PLAINSBORO, N.J., Oct.
Sign-up for Integra LifeSciences to Acquire DuraSeal(TM) Product Lines From Covidien investment picks
Digital River, Inc. (NASDAQ: DRIV ) announced new additions to its executive leadership team.
Sign-up for Digital River Appoints Ted Cahall, EVP and Chief Operating Officer, and Thomas Peterson, EVP and General Manager, Commerce investment picks
2013/10/28
PMC-Sierra, Inc. (PMC®) (Nasdaq: PMCS), the semiconductor and software solutions innovator transforming networks that connect, move and store big data, today reported results for the third quarter ended September 28, 2013.
Sign-up for PMC Reports Third Quarter 2013 Results investment picks
2013/10/28
Intevac, Inc. (Nasdaq: IVAC) today reported financial results for the quarter and nine months ended September 28, 2013.
Sign-up for Intevac Announces Third Quarter 2013 Financial Results investment picks
2013/10/28
BEDFORD, Mass.
Sign-up for Aware, Inc. Reports Third Quarter 2013 Financial Results investment picks
Covidien (NYSE: COV), a leading global provider of healthcare products, announced today that it has entered into a definitive agreement with Integra LifeSciences Corporation to sell its Confluent Surgical product line.
Sign-up for Covidien to Sell Confluent Surgical Product Line to Integra LifeSciences investment picks
2013/10/28
Plum Creek Timber Company, Inc. (NYSE: PCL) today announced that it intends to offer 14,100,000 shares of its common stock, par value $0.01 per share, in an underwritten public offering, subject to market and other conditions.
Sign-up for Plum Creek Timber Company, Inc. Announces Public Offering of Common Stock investment picks
2013/10/28
Whitestone REIT (NYSE - WSR “Whitestone”) , a fully integrated real estate company that owns, operates and re-develops Community Centered Properties TM , announced today the full exercise of the underwriters’ over-allotment option to purchase 600,000 of the Company’s common shares.
Sign-up for Whitestone REIT Announces Full Exercise of Underwriters’ Over-Allotment Option to Purchase Additional Shares investment picks
Riverbed Technology (NASDAQ:RVBD), the application performance company, today reported financial results for its third quarter ended September 30, 2013 (Q3’13). GAAP revenue for Q3’13 was $262 million, compared to $219 million in the third quarter of 2012 (Q3’12), representing 20% year-over-year growth.
Sign-up for Riverbed Technology Reports Third Quarter 2013 Results investment picks
2013/10/28
Plum Creek Timber Company, Inc. (NYSE: PCL) today announced it has signed a $1.1 billion purchase and sale agreement to acquire approximately 501,000 acres of industrial timberlands, associated wind and mineral assets, and an interest in approximately 109,000 acres of high-value rural and development-quality lands from MeadWestvaco Corporation (NYSE:MWV). The transaction is subject to the satisfaction of usual and customary closing conditions and is expected to close during the fourth quarter of 2013.
Sign-up for Plum Creek Timber Company, Inc. to Acquire Southern Timberlands and Interest in South Carolina Development Lands investment picks
2013/10/28
Growth in sales and solid earnings; Ongoing strength in capital ratios CARMEL, Ind.
Sign-up for CNO Financial Group reports third quarter 2013 results investment picks
Ducommun Incorporated (NYSE:DCO) (“Ducommun” or the “Company”) today reported results for its third quarter and the nine months ended September 28, 2013.
Sign-up for Ducommun Reports Results for the Third Quarter Ended September 28, 2013 investment picks
Start Premium Trial Register For Free

P F Fund Financial Data (13,000+ funds)
P F Stock Financial Data (7,000+ stocks)
P F Stock and Fund Screeners (basic)
P F Investing Articles and Market Commentary
P F Articles Archive (>30 days)
P F Discuss (dozens of stock, fund, bond, and general bulletin boards)
P F Portfolio Manager (basic)
P F Morningstar Investment Classroom
P F Access Your Portfolio Anytime, Anywhere via Your Mobile Device
P   Morningstar Fund Analyst Reports (full research on 1,700 funds, ETFs, and CEFs)
P   Morningstar Stock Analyst Reports (full research on more than 1,100 stocks)
P   Portfolio Manager (advanced with 10 X-Ray analyses, including recommendations)
P   Portfolio Monitor (monthly and on-demand personalized portfolio statements)
P   Morningstar Proprietary Stock Information (stock star ratings, buy/sell prices, economic moat ratings, and more)
P   Morningstar 5-Star Stock and Fund Favorites & Red Flags eNewsletters
P   Premium Stock and Fund Screeners (advanced with nearly infinite ways to find the best securities for you)
P   Discounts on Morningstar newsletters, books, seminars, and more

Sign-up to Morningstar


Basic Access

Articles and Videos
Morningstar video reports, articles, data, and tools. Dig into our lineup of e-newsletters and investing classroom courses outlining sensible strategies for maximizing your investments.
Morningstar Discuss
Follow the buzz on individual stocks or fund families. Plus, read the latest posts from Morningstar members and analysts.
Portfolio Manager
Track your investments and watch lists with our Portfolio Manager. Customize your view with our comprehensive stock, fund, and ETF data.

Access these features and more when you sign up for Free Membership.
Join Morningstar today. It's Free.

Unlimited Access

Analyst Research
Gather in-depth, actionable insight on over 3,700 stock and mutual funds covered by Morningstar analysts. View our mutual fund Analyst Reports favored by professionals, savvy experienced investors, and new investors researching options for retirement savings, college plans, or other investment needs.
Portfolio X-Ray®
Ensure your portfolio is positioned exactly how you want with Morningstar's X-Ray Interpreter and Stock Intersection tools. A Barron's "Best of the Web" award winner for five years running, X-Ray Interpreter goes under the hood of your portfolio to provide a useful allocation, sector, and geographic analysis. And you can discover how much of a stock you really own, individually and through mutual funds, with Stock Intersection.
Investment Picks
Find new 5-star stocks (greatly undervalued companies) to consider daily. Our 5-star stock rating is a proven winner, consistently beating benchmarks like the S&P 500. Plus, browse our Fund Analyst Picks and Stewardship Grades to find shareholder-friendly mutual funds that are poised for outperformance.
Portfolio Monitor
Get a clear view of your investments with personalized reports about your portfolio. Receive monthly statements and generate reports on-demand to help you stay on track to meet your investment goals.

Access these features and more when you sign up for Premium Membership.
Start your free 14-day trial today online
Your subscription may be tax deductible. Please contact your tax advisor.

Articles From: OFG Bancorp Reports 3Q13 Results to Ducommun Reports Results for the Third Quarter Ended September 28, 2013
Name |  Ticker |  Star Rating |  Market Cap |  Stock Type |  Sector |  Industry Star Rating |  Investment Style |  Total Assets |  Category |  Top Holdings |  Top Sectors |  Symbol |  Title Star Rating |  Category |  Total Assets |  Top Holdings |  Top Sectors |  Symbol |  Name Topic |  Sector |  Key Indicators |  User Interest |  Market Cap |  Industry Name |  Ticker |  Star Rating |  Market Cap |  Stock Type |  Sector |  Industry Star Rating |  Investment Style |  Total Assets |  Category |  Top Holdings |  Top Sectors |  Symbol / Ticker |  Title Star Rating |  Category |  Total Assets |  Symbol / Ticker |  Name Title |  Date |  Author |  Collection |  Popularity |  Interest Title |  Date |  Company |  Symbol |  Interest |  Popularity Title |  Date |  Company |  Symbol |  Interest |  Popularity